Cutaneous Manifestations of COVID-19: Review Article | ||
| The Egyptian Journal of Hospital Medicine | ||
| Article 153, Volume 97, Issue 1, October 2024, Pages 4482-4484 PDF (467.76 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhm.2024.397698 | ||
| Abstract | ||
| Background: In December 2019, a new infectious pathogen known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was discovered in Wuhan, China. The infection that caused the 2019 Coronavirus (COVID-19) disease was SARS-COV-2 distributed by respiratory drops. This novel COVID-19 infection is known to mostly induce respiratory failure and interstitial pneumonia; however, it is also frequently linked to cutaneous symptoms. Objective: This review article aimed to throw the light on cutaneous manifestations associated with COVID-19 infection. Material and methods: In our search for information on cutaneous manifestations associated with COVID-19, we used Google Scholar, Science Direct, PubMed, and other internet databases for COVID- 19 and Cutaneous manifestations. Additionally, the writers combed through relevant literature for references; however, they only included research that were either very recent or thorough, covering the years from 2010 to 2023. Due of lack of translation-related sources, documents in languages other than English were excluded. Excluded from consideration were works in progress, unpublished publications, abstracts from conferences, and dissertations that did not form part of broader scientific investigations. Conclusion: These COVID-19 symptoms fall into seven different categories: Alopecia and herpes zoster are among the following: (1) A skin rash resembling frostbite (similar to the toes of COVID-19), (2) A skin rash resembling hives, (3) A maculopapular rash, (4) A vesicular rash, (5) Purpura, (6) Reticular and necrotic lesions and (7) urticarial vasculitis. Vasculitic and inflammatory skin manifestations are the two main categories into which the pathophysiology of skin eruptions can be separated. Numerous skin conditions linked to COVID-19 have been documented, and the underlying mechanism has been partially clarified. For example, although it was formerly referred to as COVID-toe and was thought to be a cutaneous eruption connected with COVID-19, several articles have declared that it is irrelevant to COVID-19 infection. Certain skin reactions linked to COVID-19 can actually be mistaken for drug outbreaks. The mechanisms of skin reactions linked to COVID-19 must be clarified in the future, and causal linkages must be confirmed. | ||
| Keywords | ||
| COVID-19; Cutaneous manifestations; Chilblain-like | ||
|
Statistics Article View: 113 PDF Download: 110 |
||
